Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.73% | -18.62% | -15.42% | -50.31% | -97.52% |
| Total Depreciation and Amortization | -8.06% | -1.72% | -5.26% | -3.51% | 8.77% |
| Total Amortization of Deferred Charges | -14.29% | -21.43% | 44.44% | -- | -- |
| Total Other Non-Cash Items | -141.76% | -16.42% | 28.53% | 50.91% | 27.71% |
| Change in Net Operating Assets | 726.82% | -441.25% | 249.12% | -60.47% | 1.49% |
| Cash from Operations | 37.48% | -95.64% | -9.25% | -84.29% | -109.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.75% | -93.96% | -195.35% | 114.39% | -- |
| Cash from Investing | 25.75% | -93.95% | -195.35% | 114.39% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 85.19% | 2,108.74% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 818.33% | 149.83% | 27,042.48% | -- |
| Foreign Exchange rate Adjustments | 50.00% | 500.00% | -200.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,700.00% | -442.82% | -282.66% | 175.24% | -99.48% |